Hirofumi Teshima
- Epidemiology top 10%
- Infectious Diseases top 5%
- Oncology top 10%
- Hematology top 5%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Minoru YoshidaK ShimadaHideyo YamaguchiAtsushi HoriuchiTakeshi MoriS KohnoHiroshi IwasakiTaminori Obayashi
- Topics
- Lymphoma Diagnosis and Treatment (14 papers)Hematopoietic Stem Cell Transplantation (10 papers)Chronic Myeloid Leukemia Treatments (5 papers)
- Journals
- The LancetBloodCancer
- Partner nations
- JapanUnited States
In The Last Decade
Hirofumi Teshima
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Epidemiology 433
- Infectious Diseases 373
- Oncology 315
- Hematology 280
- Pathology and Forensic Medicine 205
Countries citing papers authored by Hirofumi Teshima
This map shows the geographic impact of Hirofumi Teshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Teshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Teshima more than expected).
Fields of papers citing papers by Hirofumi Teshima
This network shows the impact of papers produced by Hirofumi Teshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Teshima. The network helps show where Hirofumi Teshima may publish in the future.
Co-authorship network of co-authors of Hirofumi Teshima
This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Teshima. A scholar is included among the top collaborators of Hirofumi Teshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Teshima. Hirofumi Teshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 8 | |
| 4 | 7 | |
| 5 | 49 | |
| 6 | 7 | |
| 7 | 9 | |
| 8 | 55 | |
| 9 | 13 | |
| 10 | 4 | |
| 11 | 6 | |
| 12 | 73 | |
| 13 | 1 | |
| 14 | 21 | |
| 15 | 1 | |
| 16 | 53 | |
| 17 | 5 | |
| 18 | Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. | 44 |
| 19 | Interstitial pneumonitis in allogeneic bone marrow transplantation: a report from the Japanese BMT Study Group. | 7 |
| 20 | 2 |
About Hirofumi Teshima
Hirofumi Teshima is a scholar working on Hematology, Microbiology and Pathology and Forensic Medicine, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (280 citations), Infectious Diseases (373 citations) and Genetics (191 citations). Hirofumi Teshima has collaborated with scholars based in Japan and United States. Frequent co-authors include Minoru Yoshida, K Shimada, Hideyo Yamaguchi, Atsushi Horiuchi, Takeshi Mori, S Kohno, Hiroshi Iwasaki, Taminori Obayashi, Hajime Goto and Akira Ito. Their work appears in journals such as The Lancet, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.